
NeurologyLive® Friday 5 — July 17, 2026
Key Takeaways
- Evidence from retired elite soccer players associates repetitive head impacts with persistent neurologic symptoms and measurable brain structural differences, underscoring the need for mechanistic and longitudinal follow-up.
- A culinary medicine intervention is being evaluated to improve MIND diet adherence and mood outcomes among older adults living with type 2 diabetes.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 17, 2026.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Click the read more or watch now buttons for more details and information about each highlight.
1: Long-Term Brain Health in Former Soccer Players: Caleigh Lynch, MSc, and Thomas Parker, PhD
In a recent interview at AAIC 2026, Caleigh Lynch, MSc, and Thomas Parker, PhD, talked about the potential neurological effects of repetitive head impacts in retired elite soccer players, with findings offering new insights into symptoms, brain structure, and future research directions. [WATCH TIME: 3 Minutes]
2: Improving MIND Diet Adherence Through Culinary Medicine in Older Adults With Diabetes: Mirnova Ceide, MD, MS
In a recent interview at AAIC 2026, Mirnova Ceide, MD, MS, associate professor of neurology at Albert Einstein College of Medicine, discussed a culinary medicine intervention to improve MIND diet adherence and mood in older adults with type 2 diabetes. [WATCH TIME: 5 minutes]
3: Optimizing Amyloid Biomarker Use to Guide Antiamyloid Immunotherapy Eligibility in Alzheimer Disease: Suzanne Schindler, MD, PhD
In a recent interview at AAIC 2026, Suzanne Schindler, MD, PhD, professor of neurology at Washington University in St. Louis, discussed how integrating clinical assessment with amyloid biomarkers can improve diagnostic accuracy in Alzheimer disease. [WATCH TIME: 5 minutes]
4: NeuroVoices: Jeff Dage, PhD, on Clinical Implementation of Blood-Based Biomarkers in Alzheimer Disease
In our latest NeuroVoices Q&A, Jeff Dage, PhD, senior research professor of neurology at Indiana University School of Medicine, discussed the evolving role of blood-based Alzheimer disease biomarkers, particularly p-tau217, at AAIC 2026.
5: Using Sensory-Based Interventions for Older Adults With Dementia: Elizabeth Rhodus, PhD, MS, OTR/L
In a recent interview at AAIC 2026, Elizabeth Rhodus, PhD, MS, OTR/L, assistant professor in the Department of Behavioral Science at the University of Kentucky, discussed a nonpharmacologic intervention designed to address sensory processing impairments in older adults with dementia. [WATCH TIME: 5 minutes]
Which conversation stood out most to you in this week’s NeurologyLive Friday Five?
Don’t have time to read or watch a full video interview?


















